Finance

Beta
Ask
Lists
PHAT:NASDAQ
Phathom Pharmaceuticals Inc
$11.00
0.00%
(0.00) 1D
$10.85
-1.36% (-0.15)
Pre-market
Closed: Jun 17, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PHAT...
Open
$10.49
High
$11.18
Low
$10.49
Mkt. cap
877.32M
Avg. vol.
1.07M
Volume
710.00
52-wk high
$18.31
52-wk low
$7.61
EPS
-$2.11
Beta
0.50
Shares outstanding
79.76M
No. of employees
371
Open
$10.49
High
$11.18
Low
$10.49
Mkt. cap
877.32M
Avg. vol.
1.07M
Volume
710.00
52-wk high
$18.31
52-wk low
$7.61
EPS
-$2.11
Beta
0.50
Shares outstanding
79.76M
No. of employees
371
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to PHAT in the past 3 months
Strong Buy
Buy
5
Hold
1
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for PHAT in the last 3 months.
Highest
Current $11.00
$28.00 (+154.55%)
Average
$24.25 (+120.45%)
Lowest
$18.00 (+63.64%)
News stories
From sources across the web
About Phathom Pharmaceuticals Inc
CEO-
Employees371
Founded2018
HeadquartersFlorham Park, New Jersey, United States
SectorPharmaceutical industry
Last report
Apr 30, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.18 / -$0.20
+11.04%beat
Revenue / Est. (USD)
58.30M / 57.36M
+1.64%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
39.50M
49.50M
57.58M
58.30M
Cost of goods sold
5.04M
6.19M
7.65M
12.00M
Cost of revenue
5.04M
6.19M
7.65M
12.00M
Research and development expenses
9.08M
7.03M
7.49M
7.77M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
85.31M
51.56M
48.37M
54.01M
Operating expense
94.39M
58.58M
55.86M
61.78M
Total operating expenses
99.43M
64.78M
63.51M
73.78M
Operating income
-59.92M
-15.27M
-5.93M
-15.48M
Other non operating income
-155.00K
-7.00K
-5.00K
-831.00K
EBT including unusual items
-75.81M
-29.97M
-21.15M
-30.37M
EBT excluding unusual items
-75.81M
-29.97M
-21.15M
-30.37M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-75.81M
-29.97M
-21.15M
-30.37M
Net profit margin
-191.91%
-60.55%
-36.73%
-52.09%
Earnings per share
-0.79
-0.15
-0.08
-0.18
Interest and investment income
1.79M
1.41M
1.20M
1.74M
Interest expense
-17.52M
-16.11M
-16.42M
-15.80M
Net interest expenses
-15.73M
-14.70M
-15.22M
-14.06M
Depreciation and amortization charges
-
-
-
-
EBITDA
-59.75M
-15.12M
-5.80M
-15.37M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more